Posted in | News | Energy

Integrals Power’s LMFP Cells Pass 1,000-Cycle Milestone in QinetiQ Testing

The rich Lithium Manganese Iron Phosphate (LMFP) cathode active material developed by Integrals Power has successfully passed the 1000-cycle milestone in on-going durability testing.

LMFP battery cells assembled by QinetiQ. Image Credit: Integrals Power

The on-going test program, conducted by world-renowned testing and research company QinetiQ, has been running for more than five months and has now accumulated more than 1,000 charge and discharge cycles at 1 C rate. The LMFP material (80:20), which has been made into pouch cells by QinetiQ, has retained more than 80% of its original capacity, demonstrating exceptional durability.

Integrals Power Founder and CEO, Behnam Hormozi, said: “We believe that LMFP cells will enable EV battery packs to become less costly and less carbon-intensive to manufacture while offering the range, the long life, and the safety that EVs and other applications need to go mainstream in global markets. These latest results demonstrate to our customers that they can do exactly that, and as QinetiQ continues the test program we’re confident that the cells will still show impressive capacity retention as we progress to the next milestone.”

While awaiting the next round of test results, Integrals Power is already developing the second-generation of its LMFP material. With 30% less internal resistance than the first generation, cycle life and retained capacity are expected to be greatly improved, and preliminary tests have already shown a distinct performance improvement.

Together with the inherently lower cost than the NMC cell chemistries currently favoured by global OEMs and greater energy density offered by LFP, LMFP represents a breakthrough in cell chemistry, offering an optimal balance of the key attributes needed for EV batteries. High energy density LMFP batteries offer enhanced performance and extended operational range, making them also ideal for Maritime, Defence systems, and other demanding applications that require compact, reliable, and long-lasting power sources.

Integrals Power produced the LMFP used in the tests at its UK pilot plant in the UK, from raw materials sourced from Europe and North America, demonstrating that this next-generation cell chemistry can also break the automotive industry’s reliance on China, which currently dominates LFP production.

In light of the recent announcement from China regarding new export controls on LFP and LMFP cathode technologies, the strategic importance of developing and localizing battery materials within the UK and Europe has increased significantly. These restrictions highlight the growing fragility of global supply chains and underscore the need for sovereign capability in critical battery components. Integrals Power sees this as both a challenge and an opportunity – to accelerate the commercialization of its proprietary LMFP technology and contribute meaningfully to the resilience and independence of the UK’s energy storage ecosystem.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Integrals Power. (2025, July 18). Integrals Power’s LMFP Cells Pass 1,000-Cycle Milestone in QinetiQ Testing. AZoM. Retrieved on July 18, 2025 from https://www.azom.com/news.aspx?newsID=64758.

  • MLA

    Integrals Power. "Integrals Power’s LMFP Cells Pass 1,000-Cycle Milestone in QinetiQ Testing". AZoM. 18 July 2025. <https://www.azom.com/news.aspx?newsID=64758>.

  • Chicago

    Integrals Power. "Integrals Power’s LMFP Cells Pass 1,000-Cycle Milestone in QinetiQ Testing". AZoM. https://www.azom.com/news.aspx?newsID=64758. (accessed July 18, 2025).

  • Harvard

    Integrals Power. 2025. Integrals Power’s LMFP Cells Pass 1,000-Cycle Milestone in QinetiQ Testing. AZoM, viewed 18 July 2025, https://www.azom.com/news.aspx?newsID=64758.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.